Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ctDNA responds to neoadjuvant treatment in locally advanced rectal cancer.

Journal of cancer research and clinical oncology - 22 Sept 2024

Bürtin Florian, Elias Liema, Hinz Sebastian, Forster Michael, Hildebrandt Guido, Frerker Bernd, Bock Felix

Abstract excerpt

BACKGROUND: Liquid biopsy is a minimally invasive procedure investigating tumor mutations. METHODS: In our retrospective study, we investigated whether molecular therapy monitoring of patients receiving neoadjuvant radio(chemo)therapy on a daily routine is possible in 17 patients with locally advanced rectal cancer. Six patients received short-course radiotherapy (5 × 5 Gy) with subsequent surgery, six patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Circulating Tumor DNA

Share to Liquid Biopsy

Share to Mutation

Share to Neoadjuvant Therapy

Share to Rectal Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 39307893
DOI: 10.1007/s00432-024-05944-7
PMCID: PMC11417078

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ctDNA responds to neoadjuvant treatment in locally advanced rectal cancer.PMID 39307893Read ↗

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.Semantic proximity Read ↗

Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study.Semantic proximity Read ↗

MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer.Semantic proximity Read ↗

Whole genome sequencing of pre-treatment and post-treatment locally advanced rectal cancer using long and short read technologiesSemantic proximity Read ↗

Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions.Semantic proximity Read ↗

Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.Semantic proximity Read ↗

Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapySemantic proximity Read ↗

Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant ChemoradiotherapySemantic proximity Read ↗

ctDNA: Moving toward Clinical Utility.Semantic proximity Read ↗

Systematic Review of Candidate Single-nucleotide Polymorphisms as Biomarkers for Responsiveness to Neoadjuvant Chemoradiation for Rectal Cancer.Semantic proximity Read ↗

Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer.Semantic proximity Read ↗

Molecular diagnosis of response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.